✦ LIBER ✦

6525 POSTER Phase II study investigating the efficacy and safety of continuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Govindan, R.; Brahmer, J.R.; Novello, S.; Rosell, R.; Belani, C.P.; Atkins, J.N.; Gillenwater, H.H.; Tye, L.; Chao, R.C.; Socinski, M.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Continuous Daily Sunit

✍ G.V. Scagliotti; H.H. Gillenwater; J.R. Brahmer; R. Govindan; R. Rosell; C.P. Be 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

Phase II study of continuous daily sunit

✍ Novello, S; Scagliotti, G V; Rosell, R; Socinski, M A; Brahmer, J; Atkins, J; Pa 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 304 KB

6551 POSTER Efficacy and safety of singl

✍ von Pawel, J.; Larson, T.; Ou, S.I.; Limentani, S.A.; Sandler, A.B.; Vokes, E.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

308 A phase I–II study of the combinatio

✍ Romano, M.; Amichetti, M.; Caffo, O.; Bolner, A.; Pani, G.; Busana, L.; Galligio 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Randomised, open phase II study of toler

✍ Christian Grah; Burkhard Matthes; Helmut Happel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB

88PD EFFICACY AND SAFETY OF ERLOTINIB VE

✍ Ciuleanu, T.; Stelmakh, L.; Cicenas, S.; Gonzalez, E. Esteban 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB